This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Henry Lin in Protein Production
Introduction
Henry Lin is an accomplished inventor based in Westfield, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein production. With a total of 2 patents, Lin's work focuses on enhancing the efficiency of mammalian cell cultures.
Latest Patents
Henry Lin's latest patents include a method of increasing protein production in a Chinese hamster ovary perfusion cell culture. This invention relates to a method of culturing mammalian cells that express a heterologous protein. By increasing the potassium concentration and decreasing the molar ratio of sodium to potassium, Lin's method aims to reduce wasteful cell bleed and enhance protein production. Additionally, he has developed a serum-free perfusion medium that features a high potassium ion concentration and a low molar ratio of sodium to potassium. This medium is designed for use in culturing cells during the production phase or for minimizing cell bleed volume.
Career Highlights
Henry Lin is currently employed at Boehringer Ingelheim International GmbH, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing methods for protein production, which is crucial for various applications in medicine and research.
Collaborations
Lin collaborates with talented coworkers, including Samantha Wang and Lili Zheng. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Henry Lin's innovative approaches to protein production through his patented methods demonstrate his significant impact on biotechnology. His work not only enhances production efficiency but also contributes to the broader scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
